CBD Life Sciences, Inc. Announces Strategic MOU with U.S. Armed
Forces for Groundbreaking Mushroom Supplement
CBD Life Sciences propels its expansion with a major MOU,
positioning the company for multi-million-dollar growth in the
booming $14.6 billion adaptogens market.
SCOTTSDALE, AZ -- October 15, 2024 -- InvestorsHub NewsWire -- CBD
Life Sciences, Inc. (OTC:
CBDL) is excited to announce the signing of a game-changing
Memorandum of Understanding (MOU) with a division of the United
States Armed Forces, marking a pivotal moment in the company's
journey toward revolutionizing health and performance solutions.
While the details of the agreement are confidential, this
partnership could position CBDL at the forefront of
high-performance health solutions, creating a massive opportunity
for growth and expansion in the nutraceuticals market.
CBD Life Sciences' mushroom supplement drink powder, featuring a
powerful combination of reishi mushroom, lion's mane, and
ashwagandha root extract, is crafted to optimize mental clarity,
physical stamina, and recovery. This all-natural formula delivers
stress relief, cognitive enhancement, and immune system
support—qualities highly sought after in both the civilian and
military sectors, especially for individuals operating in
high-stress, demanding environments.
With the U.S. Armed Forces expressing interest in the company's
innovative supplement, CBD Life Sciences is positioned to redefine
how performance and health are approached, not only by elite
personnel but by health-conscious consumers around the globe. This
MOU opens a strategic door into a massive, untapped market for the
company's rapidly growing portfolio of nutraceutical
solutions.
Massive Growth, Unlimited Potential
CBD Life Sciences is no stranger to explosive growth, having
already achieved a staggering 1405.46% revenue increase since
February 2024. This meteoric rise is driven by the company's
relentless focus on innovation, product quality, and market
expansion. With the global adaptogens market expected to skyrocket
to USD 14.6 billion by 2028, CBDL is poised to capture significant
market share by tapping into this growth opportunity with unique,
scientifically backed formulations.
CEO Lisa Nelson shared, "We've been working tirelessly to create
products that not only meet the needs of health-conscious
individuals but exceed them. Our partnership with the U.S. Armed
Forces is a testament to the strength and effectiveness of our
mushroom supplement. It's a game-changer for CBD Life Sciences, and
we are incredibly excited for the opportunities it opens for our
company, shareholders, and future investors."
As CBD Life Sciences continues to expand its product line and
strategic partnerships, it offers its shareholders a unique
opportunity to be part of something transformative. This MOU will
likely serve as a major growth catalyst, not only driving the
company's revenue but also elevating its brand into new,
high-profile markets.
Why Investors Should Pay Attention
CBD Life Sciences is on the cusp of breaking through to new levels
of growth and profitability. With the company's proven track record
of success, this MOU signals a major step forward, making CBDL a
strong contender in the health and wellness industry. Current
shareholders can
anticipate sustained momentum, while prospective investors have a
rare opportunity to jump in as the company embarks on this
monumental new phase.
The signing of this MOU represents more than just a business
deal—it's a declaration of intent. CBD Life Sciences is committed
to advancing its mission of delivering world-class health products
while delivering unparalleled value to its investors. In a market
flooded with health fads and trends, CBDL is setting itself apart
with science-backed, high-demand products that address real needs
in both military and civilian populations.
Looking Ahead: A Future of Endless Possibility
As CBD Life Sciences builds on the foundation laid by its
record-breaking revenue growth, the company is strategically
positioned to push boundaries, explore new markets, and deliver
products that redefine health and wellness. Investors who recognize
the potential for growth in the adaptogens space are in a prime
position to capitalize on the rapid evolution of CBDL's brand and
reach.
About CBD Life Sciences, Inc.
CBD Life Sciences, Inc. (CBDL) is a forward-thinking, vertically
integrated CBD company that specializes in the creation of
high-quality CBD-based and nutraceutical products. The company's
commitment to innovation and natural solutions is driving its
growth and positioning it as a leader in the health and wellness
sector.
Follow our social media for the latest updates!
X:
https://www.x.com/CBDL_StockOTC
Instagram:
https://www.instagram.com/cbd.vault
IR Contact:
cbdvaultaz@gmail.com
Forward-Looking Statements
Except for the historical information contained herein, the matters
discussed in this press release are forward-looking statements.
Actual results may differ materially from those described in
forward-looking statements and are subject to risks and
uncertainties. See CBD Life Sciences, Inc's, Inc.'s filings with
OTC Markets, which may identify specific factors that may cause
actual results or events to differ materially from those described
in the forward-looking statements.
Safe Harbor Statement
This release includes forward-looking statements, which are based
on certain assumptions and reflects management's current
expectations. These forward-looking statements are subject to a
number of risks and uncertainties that could cause actual results
or events to differ materially from current expectations. Some of
these factors include: general global economic conditions; general
industry and market conditions, sector changes and growth rates;
uncertainty as to whether our strategies and business plans will
yield the expected benefits; increasing competition; availability
and cost of capital; the ability to identify and develop and
achieve commercial success; the level of expenditures necessary to
maintain and improve the quality of services; changes in the
economy; changes in laws and regulations, including codes and
standards, intellectual property rights, and tax matters; or other
matters not anticipated; our ability to secure and maintain
strategic relationships and distribution agreements. The Company
disclaims any intention or obligation to update or revise any
forward-looking ability to secure and maintain strategic
relationships and distribution agreements. The Company disclaims
any intention or obligation to update or revise any forward-looking
statements.
Contact Information:
Lisa Nelson
CEO
cbdvaultaz@gmail.com
4802091720